179 related articles for article (PubMed ID: 26486986)
1. Reduced toxicity in the treatment of locally advanced rectal cancer: a comparison of volumetric modulated arc therapy and 3D conformal radiotherapy.
Dröge LH; Weber HE; Guhlich M; Leu M; Conradi LC; Gaedcke J; Hennies S; Herrmann MK; Rave-Fränk M; Wolff HA
BMC Cancer; 2015 Oct; 15():750. PubMed ID: 26486986
[TBL] [Abstract][Full Text] [Related]
2. [Short-term efficacy comparison between preoperative three dimensional conformal radiotherapy and volumetric modulated arc therapy concurrently combined with chemotherapy in the treatment of locally advanced rectal carcinoma].
Xiao L; Yu X; Zhu Y; Xiao W; Zeng Z; Liu M; Zhang R; Gao Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Jul; 19(7):769-75. PubMed ID: 27452754
[TBL] [Abstract][Full Text] [Related]
3. A retrospective comparison of outcome and toxicity of preoperative image-guided intensity-modulated radiotherapy versus conventional pelvic radiotherapy for locally advanced rectal carcinoma.
Huang CM; Huang MY; Tsai HL; Huang CW; Ma CJ; Lin CH; Huang CJ; Wang JY
J Radiat Res; 2017 Mar; 58(2):247-259. PubMed ID: 27738080
[TBL] [Abstract][Full Text] [Related]
4. Comparison of volumetric-modulated arc therapy using simultaneous integrated boosts (SIB-VMAT) of 45 Gy/55 Gy in 25 fractions with conventional radiotherapy in preoperative chemoradiation for rectal cancers: a propensity score case-matched analysis.
Yamashita H; Ishihara S; Nozawa H; Kawai K; Kiyomatsu T; Okuma K; Abe O; Watanabe T; Nakagawa K
Radiat Oncol; 2017 Sep; 12(1):156. PubMed ID: 28934968
[TBL] [Abstract][Full Text] [Related]
5. Conventional 3D conformal radiotherapy and volumetric modulated arc therapy for cervical cancer: Comparison of clinical results with special consideration of the influence of patient- and treatment-related parameters.
Dröge LH; von Sivers FF; Schirmer MA; Wolff HA
Strahlenther Onkol; 2021 Jun; 197(6):520-527. PubMed ID: 33938967
[TBL] [Abstract][Full Text] [Related]
6. Acute toxicity with intensity modulated radiotherapy versus 3-dimensional conformal radiotherapy during preoperative chemoradiation for locally advanced rectal cancer.
Ng SY; Colborn KL; Cambridge L; Hajj C; Yang TJ; Wu AJ; Goodman KA
Radiother Oncol; 2016 Nov; 121(2):252-257. PubMed ID: 27751605
[TBL] [Abstract][Full Text] [Related]
7. Adjuvant volumetric modulated arc therapy compared to 3D conformal radiation therapy for newly diagnosed soft tissue sarcoma of the extremities: outcome and toxicity evaluation.
Di Brina L; Fogliata A; Navarria P; D'Agostino G; Franzese C; Franceschini D; De Rose F; Comito T; Bertuzzi A; Marrari A; Colombo P; Quagliuolo V; Santoro A; Scorsetti M
Br J Radiol; 2019 Oct; 92(1102):20190252. PubMed ID: 31322910
[TBL] [Abstract][Full Text] [Related]
8. Volumetric intensity-modulated arc therapy vs. 3-dimensional conformal radiotherapy for primary chemoradiotherapy of anal carcinoma: Effects on treatment-related side effects and survival.
Weber HE; Dröge LH; Hennies S; Herrmann MK; Gaedcke J; Wolff HA
Strahlenther Onkol; 2015 Nov; 191(11):827-34. PubMed ID: 26050046
[TBL] [Abstract][Full Text] [Related]
9. Can advanced new radiation therapy technologies improve outcome of high grade glioma (HGG) patients? analysis of 3D-conformal radiotherapy (3DCRT) versus volumetric-modulated arc therapy (VMAT) in patients treated with surgery, concomitant and adjuvant chemo-radiotherapy.
Navarria P; Pessina F; Cozzi L; Ascolese AM; Lobefalo F; Stravato A; D'Agostino G; Franzese C; Caroli M; Bello L; Scorsetti M
BMC Cancer; 2016 Jun; 16():362. PubMed ID: 27287048
[TBL] [Abstract][Full Text] [Related]
10. Comparison of dosimetric parameters and toxicity in esophageal cancer patients undergoing 3D conformal radiotherapy or VMAT.
Münch S; Aichmeier S; Hapfelmeier A; Duma MN; Oechsner M; Feith M; Combs SE; Habermehl D
Strahlenther Onkol; 2016 Oct; 192(10):722-9. PubMed ID: 27418129
[TBL] [Abstract][Full Text] [Related]
11. Estimation of second cancer risk after radiotherapy for rectal cancer: comparison of 3D conformal radiotherapy and volumetric modulated arc therapy using different high dose fractionation schemes.
Zwahlen DR; Bischoff LI; Gruber G; Sumila M; Schneider U
Radiat Oncol; 2016 Nov; 11(1):149. PubMed ID: 27832799
[TBL] [Abstract][Full Text] [Related]
12. Comparison of three-dimensional conformal radiation therapy, intensity-modulated radiation therapy, and volumetric-modulated arc therapy in the treatment of cervical esophageal carcinoma.
Yang H; Feng C; Cai BN; Yang J; Liu HX; Ma L
Dis Esophagus; 2017 Feb; 30(2):1-8. PubMed ID: 27629865
[TBL] [Abstract][Full Text] [Related]
13. Comparative Analysis of Efficacy, Toxicity, and Patient-Reported Outcomes in Rectal Cancer Patients Undergoing Preoperative 3D Conformal Radiotherapy or VMAT.
Regnier A; Ulbrich J; Münch S; Oechsner M; Wilhelm D; Combs SE; Habermehl D
Front Oncol; 2017; 7():225. PubMed ID: 28979889
[TBL] [Abstract][Full Text] [Related]
14. Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial.
Rödel C; Graeven U; Fietkau R; Hohenberger W; Hothorn T; Arnold D; Hofheinz RD; Ghadimi M; Wolff HA; Lang-Welzenbach M; Raab HR; Wittekind C; Ströbel P; Staib L; Wilhelm M; Grabenbauer GG; Hoffmanns H; Lindemann F; Schlenska-Lange A; Folprecht G; Sauer R; Liersch T;
Lancet Oncol; 2015 Aug; 16(8):979-89. PubMed ID: 26189067
[TBL] [Abstract][Full Text] [Related]
15. Acute toxicities of patients with locally advanced rectal cancer treated with intensified chemoradiotherapy within the CAO/ARO/AIO-12 trial: comparing conventional versus VMAT planning at a single center.
Zimmermann M; Richter A; Weick S; Exner F; Mantel F; Diefenhardt M; Fokas E; Kosmala R; Flentje M; Polat B
Sci Rep; 2022 Dec; 12(1):21263. PubMed ID: 36481692
[TBL] [Abstract][Full Text] [Related]
16. Reduced acute bowel toxicity in patients treated with intensity-modulated radiotherapy for rectal cancer.
Samuelian JM; Callister MD; Ashman JB; Young-Fadok TM; Borad MJ; Gunderson LL
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1981-7. PubMed ID: 21477938
[TBL] [Abstract][Full Text] [Related]
17. Intensity-modulated radiotherapy versus three-dimensional conformal radiotherapy in rectal cancer treated with neoadjuvant concurrent chemoradiation: a meta-analysis and pooled-analysis of acute toxicity.
Wee CW; Kang HC; Wu HG; Chie EK; Choi N; Park JM; Kim JI; Huang CM; Wang JY; Ng SY; Goodman KA
Jpn J Clin Oncol; 2018 May; 48(5):458-466. PubMed ID: 29554287
[TBL] [Abstract][Full Text] [Related]
18. Dosimetric benefits of intensity-modulated radiotherapy and volumetric-modulated arc therapy in the treatment of postoperative cervical cancer patients.
Deng X; Han C; Chen S; Xie C; Yi J; Zhou Y; Zheng X; Deng Z; Jin X
J Appl Clin Med Phys; 2017 Jan; 18(1):25-31. PubMed ID: 28291936
[TBL] [Abstract][Full Text] [Related]
19. The effects of chemoradiotherapy on recurrence and survival in locally advanced rectal cancers with curative total mesorectal excision: a prospective, nonrandomized study.
Akgun E; Ozkok S; Tekin M; Yoldas T; Caliskan C; Kose T; Karabulut B; Sezak M; Elmas N; Ozutemiz O
World J Surg Oncol; 2017 Nov; 15(1):205. PubMed ID: 29166925
[TBL] [Abstract][Full Text] [Related]
20. [Feasibility study on Xelox (capecitabine plus oxapliplatin) in the volumetric modulated arc therapy (VMAT)-based preoperative chemoradiotherapy for locally advanced rectal cancer].
Xiao L; Huang R; You K; Chang H; Qiu B; Xiao W; Chen L; Gao Y; Liu M
Zhonghua Wei Chang Wai Ke Za Zhi; 2014 Mar; 17(3):219-24. PubMed ID: 24671807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
